6.390USD-0.93%Mkt Cap: 383.66M USDP/E: —Last update: 2026-06-01
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap383.66M USD
Enterprise Value198.64M USD
Revenue (TTM)217.78M USD
Gross Profit203.06M USD
Net Income (TTM)-220.47M USD
Revenue/Share3.681 USD
Last Price6.390 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees533
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)32.25
PEG2.23
EV/EBITDA-1.31
EV/Revenue0.91
P/S1.78
P/B1.17
EPS (TTM)-4.06
EPS (Forward)0.20
52W Range
4.14039% of range9.940
52W High9.940 USD
52W Low4.140 USD
Profitability
Gross Margin93.96%
Oper. Margin-97.11%
EBITDA Margin-69.78%
Profit Margin-102.02%
ROE-67.38%
ROA-45.09%
Growth
Revenue Growth3.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-109.44M USD
CapEx (TTM)998.00K USD
FCF Margin-38.18%
FCF Yield-21.67%
Net Debt-189.24M USD
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.04
Current Ratio2.16
Quick Ratio1.91
Book Value/Sh5.536 USD
Cash/Share3.364 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)14.90 USD
Target Range7.500 USD – 21.00 USD
# Analysts5
Ownership
Shares Out.60.14M
Float53.82M
Insiders6.12%
Institutions78.73%
Short Interest
Short Ratio5.4d
Short % Float11.12%
Short % Out.10.59%
Shares Short6.37M
Short (prev mo.)5.60M
Technical
SMA 506.862 (-6.9%)
SMA 2006.293 (+1.5%)
Beta0.65
S&P 52W Chg27.70%
Avg Vol (30d)1.10M
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)46.7
MACD-0.1697
MACD Signal-0.2231
MACD Hist.+0.0535
BB Upper7.446 USD
BB Middle6.517 USD
BB Lower5.588 USD
BB Width28.51%
ATR (14)0.3135 USD
Vol Ratio (20d)0.42x